YU54576A - Process for preparing 9,10-dihydroergosine and physiologically acceptable acid addition salts thereof - Google Patents

Process for preparing 9,10-dihydroergosine and physiologically acceptable acid addition salts thereof

Info

Publication number
YU54576A
YU54576A YU00545/76A YU54576A YU54576A YU 54576 A YU54576 A YU 54576A YU 00545/76 A YU00545/76 A YU 00545/76A YU 54576 A YU54576 A YU 54576A YU 54576 A YU54576 A YU 54576A
Authority
YU
Yugoslavia
Prior art keywords
dihydroergosine
preparing
acid addition
addition salts
physiologically acceptable
Prior art date
Application number
YU00545/76A
Other versions
YU40275B (en
Inventor
R Rucman
N Djordjevic
Original Assignee
Lek Tovarna Farmacevtskih
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Tovarna Farmacevtskih filed Critical Lek Tovarna Farmacevtskih
Priority to YU545/76A priority Critical patent/YU40275B/en
Priority to DE19772708042 priority patent/DE2708042A1/en
Priority to BE175372A priority patent/BE851961A/en
Priority to SE7702254A priority patent/SE7702254L/en
Priority to AT134577A priority patent/AT352301B/en
Priority to DD7700197631A priority patent/DD128612A5/en
Priority to FR7706209A priority patent/FR2342979A1/en
Priority to CS771451A priority patent/CS200506B2/en
Priority to NL7702332A priority patent/NL7702332A/en
Priority to HU77LE803A priority patent/HU173239B/en
Priority to JP2290077A priority patent/JPS52156900A/en
Publication of YU54576A publication Critical patent/YU54576A/en
Publication of YU40275B publication Critical patent/YU40275B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
YU545/76A 1976-03-04 1976-03-04 Process for preparing 9,10-dihydro-ergosine and physiologically tolerated acid addition salts thereof YU40275B (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
YU545/76A YU40275B (en) 1976-03-04 1976-03-04 Process for preparing 9,10-dihydro-ergosine and physiologically tolerated acid addition salts thereof
DE19772708042 DE2708042A1 (en) 1976-03-04 1977-02-24 PROCESS FOR THE MANUFACTURING OF 9,10-DIHYDROERGOSIN AND ITS PHYSIOLOGICALLY COMPATIBLE ACID ADDITION SALT AND THEIR USE AS A MEDICINAL PRODUCT
BE175372A BE851961A (en) 1976-03-04 1977-03-01 PROCESS FOR THE PREPARATION OF 9,10-DIHYDROERGOSINE AND PHYSIOLOGICALLY ACCEPTABLE ACID ADDITION SALTS OF THE LATTER AND THEIR USE IN MEDICINE
SE7702254A SE7702254L (en) 1976-03-04 1977-03-01 PROCEDURE FOR THE PREPARATION OF 9,10-DIHYDROERGOSIN
AT134577A AT352301B (en) 1976-03-04 1977-03-01 PROCESS FOR THE PRODUCTION OF 9,10-DIHYDROERGOSIN AND ITS PHYSIOLOGICALLY COMPATIBLE ACID-ADDITION SALTS
DD7700197631A DD128612A5 (en) 1976-03-04 1977-03-02 PROCESS FOR THE PREPARATION OF 9,10-DIHYDROERGOSINE AND ITS PHYSIOLOGICALLY TRUSTED SAEURE ADDITIONAL SALTS
FR7706209A FR2342979A1 (en) 1976-03-04 1977-03-03 (9,10)-Dihydro-ergosine prepn. - by catalytic hydrogenation of ergosine in dimethylformamide using 10 percent palladium on carbon
CS771451A CS200506B2 (en) 1976-03-04 1977-03-03 Process for preparing 9,10-dohydroergosine and physiological additive salts with acids
NL7702332A NL7702332A (en) 1976-03-04 1977-03-04 PREPARATION AND USE OF 9,10-DIHYDROERGOSINE.
HU77LE803A HU173239B (en) 1976-03-04 1977-03-04 Process for producing 9,10-dihydroergozine
JP2290077A JPS52156900A (en) 1976-03-04 1977-03-04 Process for preparing 9*100dihydroergocine and physiologically acceptable acid additives thereof and application as medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU545/76A YU40275B (en) 1976-03-04 1976-03-04 Process for preparing 9,10-dihydro-ergosine and physiologically tolerated acid addition salts thereof

Publications (2)

Publication Number Publication Date
YU54576A true YU54576A (en) 1983-01-21
YU40275B YU40275B (en) 1985-12-31

Family

ID=25550399

Family Applications (1)

Application Number Title Priority Date Filing Date
YU545/76A YU40275B (en) 1976-03-04 1976-03-04 Process for preparing 9,10-dihydro-ergosine and physiologically tolerated acid addition salts thereof

Country Status (11)

Country Link
JP (1) JPS52156900A (en)
AT (1) AT352301B (en)
BE (1) BE851961A (en)
CS (1) CS200506B2 (en)
DD (1) DD128612A5 (en)
DE (1) DE2708042A1 (en)
FR (1) FR2342979A1 (en)
HU (1) HU173239B (en)
NL (1) NL7702332A (en)
SE (1) SE7702254L (en)
YU (1) YU40275B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016187522A1 (en) * 2015-05-20 2016-11-24 Noramco, Inc. Process for the preparation of oxymorphone freebase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1216213A (en) * 1954-12-03 1960-04-22 Cilag Spa Process for the preparation of dihydrogenated compounds of synthetic or natural derivatives of lysergic acid
GB1011112A (en) * 1961-05-10 1965-11-24 Sandoz Ag Improvements in or relating to ergot alkaloids
CH602765A5 (en) * 1974-09-27 1978-07-31 Sandoz Ag

Also Published As

Publication number Publication date
DE2708042A1 (en) 1977-09-08
DD128612A5 (en) 1977-11-30
ATA134577A (en) 1979-02-15
BE851961A (en) 1977-07-01
SE7702254L (en) 1977-09-05
AT352301B (en) 1979-09-10
FR2342979A1 (en) 1977-09-30
NL7702332A (en) 1977-09-06
HU173239B (en) 1979-03-28
CS200506B2 (en) 1980-09-15
JPS52156900A (en) 1977-12-27
FR2342979B1 (en) 1980-10-03
YU40275B (en) 1985-12-31

Similar Documents

Publication Publication Date Title
YU201280A (en) Process for preparing new 2,4,6-triiodo-isophthalic acid derivatives
HU177900B (en) Process for preparing 7alpha-methoxy-7beta-malonamido-3-/1,3,4-thiadiazoly-5-yl/-thiomethy/-1-dethia-1-oxa-3-cefem-4-carboxylic acid derivatives
PH12784A (en) 5-droxy-5-fluorocytidine,5-deoxy-5-fluorouridine and pharmaceutically acceptable acid addition salts thereof
PT66271B (en) Process for the preparation of a parasiticidal compositioncontaining 4,5-dichloro-imidazole-2-carboxilic acid derivatives and salts thereof
PT66886A (en) Process for preparing azolyl-carboxylic acid derivatives and their physiologically tolerated salts with fungicidal effect
ATA387777A (en) Process for the preparation of the novel 17,18- dehydroapovincaminol and its acid addition salts
YU40505B (en) Process for producing d,1-5methyl-tetrahydro-folic acid and salts thereof
YU126276A (en) Process for preparing new propargyl-2-phenylamino-imidazolines-(2) and acid addition salts thereof
DE3063958D1 (en) Process for preparing 4,4'-dinitrostilbene-2,2'-disulfonic acid and its salts and its use
IL52424A (en) 2,7-dihydroxy-5-isopropyliden-9-alkyl-2,6-methano-3,4,5,6-tetrahydro-2h-1-benzoxocin derivatives and process for their preparation
IL59760A0 (en) 7-oxo-4-thia-1-aza-bicyclo(3,2,0)-heptane-2-carboxylic acid derivatives,and process for their preparation
GB1538705A (en) 1,4-dihydropyridine-sugar derivatives process for their preparation and their use as medicaments
IL52099A (en) 5,6-dihydroprostacyclin derivatives and process for their preparation
HU174318B (en) Process for preparing 2,4-diamino-5-/3',4',5'-trimethoxybenzyl/-pyrimidine
YU182178A (en) Process for obtaining dibenzo(d.g.)(1,3,6)dioxazocine derivatives and acid addition salts thereof
HU175287B (en) Process for preparing new 3-amino-17alpha-aza-d-homo-androstane derivatives, further acid addition and quaternarnary salts thereof
YU54576A (en) Process for preparing 9,10-dihydroergosine and physiologically acceptable acid addition salts thereof
GB1520818A (en) Process for preparing 3,3-dimethylpent-4-enoic acid
GB2008116B (en) Process for preparing 2,5-diketogluconic acid
YU197782A (en) Process for obtaining new pyrido(1,2-a0pyrimidine derivatives, and optically active and physiologically tolerated salts thereof
ZA77200B (en) Herbicidally active 5-alkylureido-1,3,4-thiadiazol-2-yl-sulphonyl-acetic acid derivatives,process for their manufacture and their use
HU173514B (en) Process for preparing 2,3-dichloro-4-/2-tenoyl/-phenoxy-malonic acid derivatives
HU177732B (en) Process for producing 10-bromo-vincamine and acid additional salts thereof,and 10-bromo-14-epivincamine
ZA777604B (en) N-substituted 1,2,2-trimethyl-3-carbamoyl-cyclopentane-carboxylic acids,their physiologically compatible salts and a process for preparing these compounds
CS184526B1 (en) 2'-halogen-2'-deoxy-5-fluoruridine,3',5-di-o-benzoyl-derivatives and process for preparing thereof